ATXS — Astria Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Astria Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	44.9	126	226	247	328
Prepaid Expenses
Total Other Current Assets
Total Current Assets	46.3	127	228	251	335
Net Property, Plant And Equipment	0.966	0.394	0.948	0.363	5.11
Other Long Term Assets
Total Assets	47.5	128	231	255	342
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	6.39	5.2	9.06	11.6	19.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.79	5.2	9.42	11.6	23.1
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	40.7	122	221	243	319
Total Liabilities & Shareholders' Equity	47.5	128	231	255	342
Total Common Shares Outstanding
Total Preferred Shares Outstanding